Evidence map›Paper›PMID 32884936›Full record

Trial reportBioMed research international2020

Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1

Tianbiao Zhou, Wenshan Lin, Shujun Lin, Zhiqing Zhong, Yuanyuan Luo, Zhijun Lin, Weiji Xie, Weitao Shen, Kai Hong

Abstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. The effect ofTranslational andrology and urology · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tianbiao ZhouDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.ORCID https://orcid.org/0000-0001-8065-1644
Wenshan LinDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Shujun LinDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Zhiqing ZhongDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Yuanyuan LuoDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Zhijun LinDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Weiji XieDepartment of Nephrology, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Weitao ShenDepartment of Clinical Laboratory, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.
Kai HongDepartment of Clinical Laboratory, The Second Affiliated Hospital, Shantou University Medical College, 515041 Shantou, China.ORCID https://orcid.org/0000-0002-7114-4517

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear receptor coactivators (NCOAs), consisting of coactivators and corepressors, dramatically enhance the transcriptional activity of nuclear receptors. Hypoxia-inducible factor-1

Indexed as

AdultFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitMaleNuclear Receptor CoactivatorsRenal Insufficiency, ChronicVascular Endothelial Growth Factor AHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitNuclear Receptor CoactivatorsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID32884936
PMCPMC7455818

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.